This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (120)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Topic Collections  • Dermatologic Disorders  • Herpes  • Hypersensitivity  • Drug Therapy  • Adverse Effects  • Alert me on articles by topic  Social Bookmarking   What's this?

Vincent Descamps, MD, PhD; Annabel Valance, MD; Catherine Edlinger, MD; Anne-Marie Fillet, MD, PhD; Maggy Grossin, MD; Bénédicte Lebrun-Vignes, MD; Stéphane Belaich, MD; Béatrice Crickx, MD

Arch Dermatol. 2001;137:301-304.

Background  There is a current debate regarding the association of human herpesvirus 6 (HHV-6) infection and drug reaction with eosinophilia and systemic symptoms (DRESS).

Methods  Seven consecutive patients hospitalized with DRESS were enrolled in a prospective study to evaluate evidence of active HHV-6 infection.

Observations  The imputable drugs were carbamazepine (5 patients), ibuprofen (1 patient), and sulfasalazine (1 patient). All patients were seropositive for anti–HHV-6 IgG antibodies. Anti–HHV-6 IgM antibodies were detected in 4 of the 7 patients with a seroconversion in 2 patients. Neither anti-cytomegalovirus nor anti–Epstein-Barr virus early antigen IgM antibody was detected. Human herpesvirus 6 genome was not detected by polymerase chain reaction in the first serum sample of all patients. It was weakly detected in skin lesions in the last patient tested by polymerase chain reaction but was not found in uninvolved skin.

Conclusions  The results suggest an association between HHV-6 active infection (primo-infection or reactivation) and severe DRESS. Absence of anti-cytomegalovirus or anti–Epstein-Barr virus early antigen IgM antibodies argues against a nonspecific viral reactivation. Human herpesvirus 6 infection may play a role in the development of DRESS in susceptible patients. Some drugs with reactive metabolites could favor reactivation and propagation of HHV-6.

From the Departments of Dermatology (Drs Descamps, Valance, Lebrun-Vignes, Belaich, and Crickx), Anatomopathology (Dr Grossin), and Virology (Dr Edlinger), Hôpital Bichat-Claude Bernard, and the Virology Department, Hôpital Pitié-Salpétrière, Assistance Publique— Hôpitaux de Paris (Dr Fillet), Paris, France.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

The Drug Hypersensitivity Syndrome: What Is the Pathogenesis?
John R. Sullivan and Neil H. Shear
Arch Dermatol. 2001;137(3):357-364.
EXTRACT | FULL TEXT  

Archives of Dermatology Reader's Choice: Continuing Medical Education
Arch Dermatol. 2001;137(3):393.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Killing with kindness? Drug reaction eosinophilia with systemic symptoms (DRESS) masquerading as acute severe sepsis
Horsfield et al.
J Antimicrob Chemother 2009;64:663-665.
FULL TEXT  

Twelve-Year Analysis of Severe Cases of Drug Reaction With Eosinophilia and Systemic Symptoms: A Cause of Unpredictable Multiorgan Failure
Eshki et al.
Arch Dermatol 2009;145:67-72.
ABSTRACT | FULL TEXT  

DRESS Syndrome: A Practical Approach for Primary Care Practitioners
Seth et al.
CLIN PEDIATR 2008;47:947-952.
 

Toxic Epidermal Necrolysis Due to Zonisamide Associated With Reactivation of Human Herpesvirus 6
Teraki et al.
Arch Dermatol 2008;144:232-235.
ABSTRACT | FULL TEXT  

Sulfamethoxazole and Its Metabolite Nitroso Sulfamethoxazole Stimulate Dendritic Cell Costimulatory Signaling
Sanderson et al.
J. Immunol. 2007;178:5533-5542.
ABSTRACT | FULL TEXT  

Association Between Anticonvulsant Hypersensitivity Syndrome and Human Herpesvirus 6 Reactivation and Hypogammaglobulinemia
Kano et al.
Arch Dermatol 2004;140:183-188.
ABSTRACT | FULL TEXT  

Is a Drug Alone Sufficient to Cause the Drug Hypersensitivity Syndrome?
Wong and Shear
Arch Dermatol 2004;140:226-230.
FULL TEXT  

Delayed Drug Hypersensitivity Reactions
Pichler
ANN INTERN MED 2003;139:683-693.
ABSTRACT | FULL TEXT  

Covalent Binding of the Nitroso Metabolite of Sulfamethoxazole Leads to Toxicity and Major Histocompatibility Complex-Restricted Antigen Presentation
Naisbitt et al.
Mol. Pharmacol. 2002;62:628-637.
ABSTRACT | FULL TEXT  

Elucidation of the Cross-Reactive Immunoglobulin M Response to Human Herpesviruses 6 and 7 on the Basis of Neutralizing Antibodies
Yoshida et al.
CVI 2002;9:394-402.
ABSTRACT | FULL TEXT  

Drug Hypersensitivity Syndrome and Human Herpesvirus 6 Reactivation
Tohyama et al.
Arch Dermatol 2002;138:268-269.
FULL TEXT  

The Drug Hypersensitivity Syndrome: What Is the Pathogenesis?
Sullivan and Shear
Arch Dermatol 2001;137:357-364.
FULL TEXT